Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Iovance Biotherapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 242
- +5 vs. Q2 2022
- Shares held
- 154.2M
- −5.11M (−3.2%) vs. Q2 2022
- Total value
- $1.48B
- −$269.3M (−15.4%) vs. Q2 2022
- New holders
- 31
- 81 more added
- Sold out
- 26
- 87 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nomura Holdings Inc | 981,284 | $9.40M | 0.09% | −168,117−14.6% | Reduced |
| Aristotle Atlantic Partners, LLC | 1,016,649 | $9.74M | 0.59% | +5,840+0.6% | Added |
| Soleus Capital Management, L.P. | 1,025,200 | $9.82M | 1.33% | +305,600+42.5% | Added |
| Charles Schwab Investment Management Inc | 1,027,460 | $9.84M | 0.00% | +26,988+2.7% | Added |
| Morgan Stanley | 1,048,000 | $10.0M | 0.00% | −402,057−27.7% | Reduced |
| Principal Financial Group Inc | 1,067,432 | $10.2M | 0.01% | +150,749+16.4% | Added |
| C WorldWide Group Holding A/S | 1,160,000 | $11.1M | 0.15% | 00.0% | Unchanged |
| Millennium Management LLC | 1,220,965 | $11.7M | 0.01% | −190,222−13.5% | Reduced |
| Avidity Partners Management LP | 1,382,900 | $13.2M | 0.29% | −9,400−0.7% | Reduced |
| Norges Bank | 1,396,357 | $13.4M | 0.00% | +42,122+3.1% | Added |
| Two Sigma Investments, LP | 1,411,158 | $13.5M | 0.05% | +877,558+164.5% | Added |
| Rice Hall James & Associates, LLC | 1,434,056 | $13.7M | 0.80% | −267,135−15.7% | Reduced |
| Voloridge Investment Management, LLC | 1,443,048 | $13.8M | 0.07% | +437,941+43.6% | Added |
| Northern Trust Corp | 1,579,942 | $15.1M | 0.00% | −17,155−1.1% | Reduced |
| Finepoint Capital LP | 1,586,043 | $15.2M | 5.00% | +625,843+65.2% | Added |
| Wellington Management Group LLP | 1,639,535 | $15.7M | 0.00% | +305,473+22.9% | Added |
| Dimensional Fund Advisors LP | 1,662,513 | $15.9M | 0.01% | +415,153+33.3% | Added |
| Candriam Luxembourg S.C.A. | 1,668,920 | $16.0M | 0.11% | +40,000+2.5% | Added |
| MPM Oncology Impact Management LP | 1,700,000 | $16.3M | 3.86% | +500,000+41.7% | Added |
| 683 Capital Management, LLC | 1,705,000 | $16.3M | 1.32% | −295,000−14.8% | Reduced |
| Nuveen Asset Management, LLC | 1,738,385 | $16.7M | 0.01% | −60,164−3.3% | Reduced |
| Balyasny Asset Management LLC | 1,743,532 | $16.7M | 0.06% | +233,743+15.5% | Added |
| Boxer Capital, LLC | 1,935,133 | $18.5M | 1.04% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,007,458 | $19.2M | 0.38% | −790,983−28.3% | Reduced |
| JPMorgan Chase & Co | 2,113,278 | $20.2M | 0.00% | +71,609+3.5% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,317,217 | $22.2M | 0.15% | −618,462−21.1% | Reduced |
| Ameriprise Financial Inc | 2,512,167 | $24.1M | 0.01% | −497,847−16.5% | Reduced |
| Credit Suisse AG | 2,609,705 | $25.0M | 0.03% | −28,597−1.1% | Reduced |
| Nikko Asset Management Americas, Inc. | 2,699,413 | $25.2M | 0.32% | −100,229−3.6% | Reduced |
| Geode Capital Management, LLC | 2,672,158 | $25.6M | 0.00% | +32,269+1.2% | Added |
| D. E. Shaw & Co., Inc. | 2,695,220 | $25.8M | 0.05% | +617,689+29.7% | Added |
| Sumitomo Mitsui Trust Holdings, Inc. | 2,699,413 | $25.9M | 0.02% | −100,229−3.6% | Reduced |
| Artisan Partners Limited Partnership | 2,758,573 | $26.4M | 0.05% | −20,229−0.7% | Reduced |
| Goldman Sachs Group Inc | 2,994,979 | $28.7M | 0.01% | +1,042,633+53.4% | Added |
| Pictet Asset Management SA | 3,982,344 | $38.2M | 0.06% | +349,506+9.6% | Added |
| Price T Rowe Associates Inc | 4,711,314 | $45.1M | 0.01% | +360,629+8.3% | Added |
| Franklin Resources Inc | 5,182,146 | $49.6M | 0.03% | +14,639+0.3% | Added |
| Avoro Capital Advisors LLC | 9,020,000 | $86.4M | 1.60% | −200,000−2.2% | Reduced |
| State Street Corp | 9,932,152 | $95.2M | 0.01% | −1,838,599−15.6% | Reduced |
| Perceptive Advisors LLC | 10,248,624 | $98.2M | 2.85% | −1,577,675−13.3% | Reduced |
| BlackRock Inc. | 11,466,492 | $109.8M | 0.00% | −104,574−0.9% | Reduced |
| Vanguard Group Inc | 14,253,754 | $136.6M | 0.00% | +890,727+6.7% | Added |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −3,176,773−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −271,534−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −114,431−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −107,782−100.0% | Sold out |
| Kettle Hill Capital Management, LLC | 0 | $0 | 0.00% | −81,958−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −81,549−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −71,000−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −40,248−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −29,996−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −24,704−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −14,467−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −12,050−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,744−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −10,325−100.0% | Sold out |
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −6,625−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −2,283−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,474−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −560−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| ACG Wealth | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −121−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Exane Derivatives | – | – | – | – | Not filed |